URGN
UroGen Pharma Ltd.
$19.45
+$0.21(+1.09%)
75
Overall
--
Value
75
Tech
--
Quality
Market Cap
$902.15M
Volume
1.29M
52W Range
$3.42 - $21.02
Target Price
$33.67
Key Metrics Overview
| Market Cap | $902.15M | P/E Ratio | N/A |
| 52W High | $21.02 | 52W Low | $3.42 |
| Div Yield | N/A | Payout Ratio | N/A |
| EPS Growth 3Y | 12.1% | 52W Position | 91.1% |
| Overall Score | 75 | Value Score | -- |
| Quality Score | -- | Technical Score | 75 |
Growth Analysis
| EPS Current Est | $-3.06 | EPS Next Est | $-1.45 |
| EPS Growth Est | N/A | DPS Growth 3Y | N/A |
Revenue (5Y)
EBITDA (5Y)
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | URGN | $19.45 | +1.1% | 1.29M |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |